49 results
424B3
CMRA
Comera Life Sciences Holdings, Inc.
9 Nov 23
Prospectus supplement
4:36pm
Comera’s innovative proprietary formulation platform, SQore™. Comera also collaborates with pharmaceutical and biotechnology companies, applying … portfolio of proprietary therapeutic product candidates using its innovative proprietary formulation platform, SQore™. Comera also collaborates
424B3
CMRA
Comera Life Sciences Holdings, Inc.
9 Nov 23
Prospectus supplement
4:35pm
Comera’s innovative proprietary formulation platform, SQore™. Comera also collaborates with pharmaceutical and biotechnology companies, applying … portfolio of proprietary therapeutic product candidates using its innovative proprietary formulation platform, SQore™. Comera also collaborates
424B3
CMRA
Comera Life Sciences Holdings, Inc.
9 Nov 23
Prospectus supplement
4:33pm
Comera’s innovative proprietary formulation platform, SQore™. Comera also collaborates with pharmaceutical and biotechnology companies, applying … portfolio of proprietary therapeutic product candidates using its innovative proprietary formulation platform, SQore™. Comera also collaborates
DEF 14A
CMRA
Comera Life Sciences Holdings, Inc.
11 Aug 23
Definitive proxy
4:15pm
to the outlicense and deployment of an innovative self-suspending proppant technology. Prior to joining Dr. Soane at Soane Energy, he was Vice President of Research … Officer at Lyvgen Biopharma Co., (“Lyvgen”) Ltd since June 2021, a private biotechnology company focused on developing innovative immuno-oncology
8-K
EX-99.1
1la98
10 Aug 23
Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business Highlights
5:30pm
424B3
rw5xw5mnepomehpk h1
10 Aug 23
Prospectus supplement
4:37pm
424B3
pqxxitmlkexhhr04q7au
10 Aug 23
Prospectus supplement
4:32pm
424B3
hwbcqk2lvh7u1vf
10 Aug 23
Prospectus supplement
4:32pm
PRE 14A
vnsa9sma0pwc mmgbdkj
1 Aug 23
Preliminary proxy
5:08pm
424B3
7bn10x iby2
16 May 23
Prospectus supplement
4:33pm
424B3
2cr1wwulzw
16 May 23
Prospectus supplement
4:31pm
424B3
6bs7qd5pmoq9
16 May 23
Prospectus supplement
4:31pm
8-K
EX-99.1
363a3ghu2ydtm4t5skyk
12 May 23
Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business Highlights
4:31pm
424B3
tq7yxp
31 Mar 23
Prospectus supplement
4:34pm
424B3
c7gnby7bl yl8142wny
31 Mar 23
Prospectus supplement
4:34pm
424B3
2l5qs6eoi65mfrq
31 Mar 23
Prospectus supplement
4:32pm
424B3
3g63116bg
14 Nov 22
Prospectus supplement
5:19pm